Phase 4 Colorectal Cancer Trial, Recruiting NCT05894694 Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 4 Colorectal Cancer Trial, Recruiting

NCT05894694
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with advanced colorectal cancer (confirmed by lab testing) and are receiving your first round of treatment for this advanced cancer
  • You are 18 years of age or older (any gender)
  • You are reasonably active and able to care for yourself, with only mild limitations on daily activities (confirm with trial site)
  • Your doctors expect you to live for at least 3 more months
  • You have at least one measurable area of cancer that can be tracked on scans
  • You are willing to participate, sign a consent form, and attend follow-up appointments

Who may not be able to join:

  • You have been diagnosed with another type of cancer in addition to colorectal cancer
  • Your cancer has been identified as a specific type called MSI-H or dMMR (a result from genetic or lab testing of your tumor — confirm with trial site)
  • Your cancer came back or spread within 6 months of having surgery intended to fully remove the tumor
  • You are currently receiving or have previously received cancer immunotherapy treatment
  • You are currently undergoing radiation therapy
  • You are pregnant or breastfeeding, or you or your partner are of childbearing age and cannot use effective contraception during the trial and for 6 months after it ends
  • You have a diagnosed psychiatric (mental health) condition
  • You have a serious, uncontrolled illness or infection, such as severe heart, lung, or kidney failure that would make chemotherapy unsafe for you
  • You have taken part in a clinical trial involving a small-molecule drug within the last 28 days, or a biological/large-molecule drug within the last 3 months (confirm with trial site)
  • You are known to be allergic to or unable to tolerate the drugs used in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 88001711

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Registry
ClinicalTrials.gov
Start date
27 September 2023
Est. completion
30 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov